SLNO Shareholders Sue Over Alleged Safety Disclosure Failures in PWS Drug Trial
Soleno Therapeutics faces securities fraud lawsuit alleging failure to disclose safety concerns about DCCR drug candidate between March 2025 and November 2026.
SLNOsecurities fraudclass action lawsuit